Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Open House Drug Discount Agreements Interferon Beta-1A, Finished Drug Name Avonex, Atc L03Ab07

AOK BAYERN - DIE GESUNDHEITSKASSE Germany has Released a tender for Open House Drug Discount Agreements Interferon Beta-1A, Finished Drug Name Avonex, Atc L03Ab07 in Pharmaceuticals. The tender was released on Apr 16, 2024.

Country - Germany

Summary - Open House Drug Discount Agreements Interferon Beta-1A, Finished Drug Name Avonex, Atc L03Ab07

Deadline - Apr 05, 2026

GT reference number - 80941882

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 80941882

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: This is not an open procedure, but rather a so-called open-house model! The form for the open process is only used because there is no form for the open-house model. Contracts concluded in the open-house model are not subject to public p rocurement law due to the lack of a selection decision. The use of this form does not involve subjection to procurement regulations. AOK Bayern intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies for the active ingredient interferon beta-1a, finished drug name Avonex, ATC L03AB07, in accordance with Section 130a Paragraph 8 SGB V. AOK Bayern offers all interested pharmaceutical companies that meet th

Gt Ref Id - 80941882

Deadline - Apr 05, 2026

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database